Filing Details

Accession Number:
0001209191-23-050685
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-27 18:36:38
Reporting Period:
2023-09-27
Accepted Time:
2023-09-27 18:36:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1782223 Pyxis Oncology Inc. PYXS Pharmaceutical Preparations (2834) 831160910
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796310 Ann Pamela Connealy C/O Pyxis Oncology, Inc.
321 Harrison Avenue
Boston MA 02118
Cfo And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-27 6,426 $1.85 810,532 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price of common stock purchased by the Reporting Person in open market transactions. The range of purchase prices on the transaction date was $1.78 to $1.87 per share. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each price.